DUCHEMBIO CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,350 KRW | -0.68% |
|
+0.68% | +33.64% |
More news
| 1 day | -0.68% | ||
| 1 week | +0.68% | ||
| Current month | +6.52% | ||
| 1 month | +5.00% | ||
| 3 months | +22.50% | ||
| 6 months | +25.43% | ||
| Current year | +33.64% |
1 week
7 200.00
7 600.00
1 month
6 800.008 000.00
Current year
5 300.008 000.00
1 year
5 050.008 000.00
3 years
4 745.0012 400.00
5 years
4 510.0013 850.00
10 years
4 510.0017 800.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jong-Woo Kim
CEO | Chief Executive Officer | 56 | 05/11/02 |
Jae-Ki Park
PSD | President | 70 | 30/04/13 |
Hyun-Joon Ha
CTO | Chief Tech/Sci/R&D Officer | 65 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gyeong-Ho Lee
BRD | Director/Board Member | 74 | 28/03/22 |
Jong-Woo Kim
CEO | Chief Executive Officer | 56 | 05/11/02 |
Bong-Seok Kim
PRN | Corporate Officer/Principal | 58 | 28/02/11 |
DuChemBio Co Ltd is a Korea-based company principally engaged in the manufacture and sale of radiopharmaceuticals. The Company is engaged in the manufacture and sale of diagnostic radiopharmaceuticals such as radiopharmaceuticals for the diagnosis of Parkinson's disease, radiopharmaceuticals for the diagnosis of Alzheimer's disease, and radiopharmaceuticals for the diagnosis of brain tumors. In addition, the Company is engaged in the sale of computed tomography (CT) contrast agents and other products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +33.64% | 144M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- A176750 Stock
